Interaction Between Inflammatory State and Neurochemical Changes in Major Psychiatric Disorders

作者: Aye Mu , Markus J

DOI: 10.5772/25532

关键词:

摘要: Inflammation is the immunological mechanism to react against danger signal. In old days, inflammation characterized by heat, redness, pain, swelling and loss of function in gross appearance inflammatory cells infiltration affected area microscopical appearance. Even though it not always possible demonstrate certain part brain patients with psychiatric disorders, there are evidences such as enhanced production mediators that indicated reaction immune system. It generally considered reactions occur response a signal abnormal cell death. With time, scientists both immunology neuroscience fields realized signals only due microorganisms, foreign bodies or tissue injury but also some noxious situations psychological emotional stress. The involvement system disorders is, fact, recognized since 1927 Wagner-Jauregg, psychiatrist who ever awarded Noble prize for his work on malaria inoculation treatment dementia paralytica (Raju, 1998) which was psychosis inducing fever, known ‘pyrotherapy’. That evidence activation induced infection could cure psychotic symptoms fever associated activation. On other hand meningitis toxic without reported Fischer, 1963. Taken together, field Medicine, relation between infection, inflammation, became interest early 20th Century. Around similar period, Biology, Selye (Selye, 1954) has neurogenic stress situation forcible immobilization effectively inhibit experimental granuloma-pouch under dorsal skin rat after chronic irritation cotton wool abolished adrenalectomized rats. finding anti-phlogistic effect suppression largely dependent secretion corticoids from adrenal glands. earliest starting point indicating although difficult conclude if

参考文章(202)
Sophie Erhardt, Sara K. Olsson, Göran Engberg, Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders. CNS Drugs. ,vol. 23, pp. 91- 101 ,(2009) , 10.2165/00023210-200923020-00001
Pertz H, Back W, [Synthesis and resolution of chiral ring-opened serotonin analogs of the 5-hydroxykynuramine type]. Pharmaceutica Acta Helvetiae. ,vol. 63, pp. 128- ,(1988)
Y Watanabe, M Fujiwara, R Yoshida, O Hayaishi, Stereospecificity of hepatic l-tryptophan 2,3-dioxygenase Biochemical Journal. ,vol. 189, pp. 393- 405 ,(1980) , 10.1042/BJ1890393
Michael Bacher, Andreas Meinhardt, Hui Y. Lan, Firdaus S. Dhabhar, Wei Mu, Christine N. Metz, Jason A. Chesney, Diethard Gemsa, Thomas Donnelly, Robert C. Atkins, Richard Bucala, MIF expression in the rat brain: implications for neuronal function. Molecular Medicine. ,vol. 4, pp. 217- 230 ,(1998) , 10.1007/BF03401919
Sophie Erhardt, Lilly Schwieler, Göran Engberg, Kynurenic acid and schizophrenia. Advances in Experimental Medicine and Biology. ,vol. 527, pp. 155- 165 ,(2003) , 10.1007/978-1-4615-0135-0_18
Lucile Capuron, Gabriele Neurauter, Dominique L Musselman, David H Lawson, Charles B Nemeroff, Dietmar Fuchs, Andrew H Miller, Interferon-alpha–induced changes in tryptophan metabolism Biological Psychiatry. ,vol. 54, pp. 906- 914 ,(2003) , 10.1016/S0006-3223(03)00173-2
John N. Aucott, Glucocorticoids and Infection Endocrinology and Metabolism Clinics of North America. ,vol. 23, pp. 655- 670 ,(1994) , 10.1016/S0889-8529(18)30091-4
DAVID A. BENDER, GWYN M. McCREANOR, Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism. Biochemical Society Transactions. ,vol. 13, pp. 441- 443 ,(1985) , 10.1042/BST0130441
A. Jäger, V. K. Kuchroo, Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scandinavian Journal of Immunology. ,vol. 72, pp. 173- 184 ,(2010) , 10.1111/J.1365-3083.2010.02432.X